Form 4: Robert W. Sharps reports acquisition/exercise transactions in TROW
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Robert W. Sharps reported acquisition or exercise transactions in a Form 4 filing for TROW. The filing lists transactions totaling 22,404 shares at a weighted average price of $103.92 per share. Following the reported transactions, holdings were 556,007 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Robert W. Sharps
Role
CEO and President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 150.264 | $103.92 | $16K |
| Grant/Award | Common Stock | 22,254 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 556,007.25 shares (Direct)
Footnotes (1)
- Shares acquired pursuant to the T. Rowe Price Group, Inc. Employee Stock Purchase Plan at the noted weighted-average price. On February 13, 2026, the Executive Compensation and Management Development Committee certified that the performance threshold on certain performance-based restricted stock awards were met. The awards are settled in shares of common stock upon vesting. The awards vest in two equal annual installments beginning on December 10, 2026.
FAQ
What insider transaction did T. Rowe Price (TROW) CEO Robert Sharps report?
Robert W. Sharps reported acquiring T. Rowe Price common stock on February 13, 2026. He bought 150.2638 shares through the Employee Stock Purchase Plan and received 22,254 performance-based restricted stock awards after performance thresholds were certified.
Why did Robert Sharps receive 22,254 performance-based TROW stock awards?
Robert W. Sharps received 22,254 performance-based restricted stock awards because the Executive Compensation and Management Development Committee certified that specified performance thresholds were met. Once vested, these awards are settled in T. Rowe Price common stock, aligning compensation with company performance.
Is Robert Sharps’ February 13, 2026 TROW transaction a stock purchase or a grant?
The Form 4 shows both an ESPP purchase and an equity grant. Sharps acquired 150.2638 shares via purchase under the Employee Stock Purchase Plan and received 22,254 performance-based restricted stock awards as a grant after performance criteria were certified.